Found 4 matching trials
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
PHASE2Adult participants with BMI between 22 - 35 kg/m2 will be enrolled and rand...
NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration
PHASE1This study will evaluate the safety, tolerability, and preliminary efficacy...
Status
Active Not Recruiting
Location
Cincinnati Eye Institute
NISCI - Nogo Inhibition in Spinal Cord Injury
PHASE2The purpose of the NISCI trial is to test if an antibody therapy can improv...
Location
Spinal Cord Unit, University Hospital Motol
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
PHASE2The purpose of this study is to assess the safety and efficacy of various d...
Location
Digestive Health Specialists